drugset / Trial / NCT02707315

A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer

NCT02707315

Phase 0 Unknown 15 enrolled The Cooper Health System
NaSingle-groupOpen-labelTreatment

Summary

This study is evaluating stereotactic radiosurgery (CyberKnife) plus chemotherapy for the treatment of potentially resectable adenocarcinoma of the pancreas

Timeline

Start
2013-01
Primary completion
2016-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 1000 mg/m2